Continuing insulin pump therapy in hospitals is feasible with proper patient selection and policy
Background
For individuals managing diabetes mellitus with insulin, continuous subcutaneous insulin infusion (CSII), commonly known as insulin pump therapy, offers precise glucose control in outpatient settings. However, hospitalization often disrupts this established regimen, frequently leading to a switch to traditional insulin injections due to concerns about safety, staff familiarity, and institutional protocols. This transition can result in suboptimal glycemic control and increased patient burden. This paper addresses the critical gap in safely and effectively transitioning patients' existing CSII therapy from home to the inpatient environment, aiming to maintain continuity of care and improve outcomes.
Study Design
This paper provides an updated summary of best practices for the transition of continuous subcutaneous insulin infusion (CSII) therapy from outpatient to inpatient settings. It synthesizes current understanding regarding patient selection criteria, necessary institutional policies, and communication strategies essential for safe and effective continuation of CSII during hospitalization. The review aims to guide healthcare professionals in managing diabetes mellitus patients who utilize insulin pumps, focusing on practical considerations for integrating this technology into hospital care.
Results
The review highlights that continuing CSII therapy in the hospital is feasible, provided specific conditions are met to ensure patient safety and effective glycemic management. Key findings emphasize the critical role of proper patient selection, ensuring individuals are capable of self-managing their pump, understanding their diabetes, and communicating effectively with staff. This includes assessing cognitive ability, vision, and overall health status.
An approved institutional policy is deemed essential, outlining clear guidelines for pump management, emergency protocols for pump malfunctions or severe hyperglycemia/hypoglycemia, and defining staff responsibilities for monitoring and support. Effective communication between the patient, their family, and the hospital staff (including nurses, physicians, and endocrinologists) is crucial for continuous monitoring, troubleshooting, and ensuring patient safety. These elements collectively enable the safe transfer and continuation of outpatient CSII therapy within the hospital environment, minimizing risks like hypoglycemia or hyperglycemia and maintaining patient autonomy.
Key Findings
- Continuing outpatient insulin pump therapy (CSII) in the hospital is feasible.
- Proper patient selection is essential for safe inpatient CSII use.
- Approved institutional policies are critical for managing CSII in the hospital.
- Effective communication between staff and patient is vital for safe CSII transition.
Why It Matters
This summary provides crucial guidance for clinicians and hospital administrators, enabling them to safely allow patients to continue their established insulin pump therapy during hospitalization. Implementing clear institutional policies and robust communication protocols can significantly improve glycemic control and patient satisfaction, reducing the stress and potential for errors associated with switching insulin regimens. For patients, this means less disruption to their daily routine and potentially better health outcomes during a vulnerable period. This framework helps standardize care, moving towards a future where personal insulin pump use is a recognized and supported option in inpatient settings, rather than an exception, thereby enhancing the quality of care for hospitalized individuals with diabetes mellitus.
insulin-pump
csii
diabetes-mellitus
hospitalization
inpatient-care
patient-management